2025Zeitschrift Fur Gastroenterologie63 (9) : 930-941
Quality of life improves during antiviral therapy with bulevirtide
Eichholz J, Dietz-Fricke C, Mrowietz S, Dinkelborg K, Port K, Wedemeyer H, Deterding K
Virology
Behrendt Lab
Publications
2025Liver International : Official Journal of the International Association for the Study of the Liver45 (9) : e70246
Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection Model
Hrabal I, Aliabadi E, Weber S, Ssebyatika G, Krey T, Holicki C, Schmid L, Dinkelborg K, Schröder C, Fast C, Behrendt P, Groschup M, Eiden M
2025Liver International : Official Journal of the International Association for the Study of the Liver45 (7) : e70183
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney
Wahid A, Meyer N, Wundes C, Hüffner L, Janshoff S, Frericks N, Friesland M, Dinkelborg K, Aliabadi E, Laue F, Cornberg M, Maasoumy B, Bremer B, Pischke S, Müller T, Wiesch J, Benckert J, Ulrich R, Hardtke S, Dörge P, Vondran F, Lohse A, Manns M, Todt D, Wedemeyer H, Pietschmann T, Steinmann E, Gömer A, Behrendt P
2025Scientific Reports15 (1) : 17845
Correction: Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody
Hrabal I, Aliabadi E, Reiche S, Weber S, Holicki C, Schmid L, Fast C, Schröder C, Gutjahr B, Behrendt P, Groschup M, Eiden M
2025Scientific Reports15 (1) : 10795
Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody
Hrabal I, Aliabadi E, Reiche S, Weber S, Holicki C, Schmid L, Fast C, Schröder C, Gutjahr B, Behrendt P, Groschup M, Eiden M
2025Nature Communications16 (1) : 1995
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice
Ssebyatika G, Dinkelborg K, Ströh L, Hinte F, Corneillie L, Hueffner L, Guzman E, Nankya P, Plückebaum N, Fehlau L, Garn J, Meyer N, Prallet S, Mehnert A, Kraft A, Verhoye L, Jacobsen C, Steinmann E, Wedemeyer H, Viejo-Borbolla A, Dao Thi V, Pietschmann T, Lütgehetmann M, Meuleman P, Dandri M, Krey T, Behrendt P
2024Nature Communications15 (1) : 4855
Genetic determinants of host- and virus-derived insertions for hepatitis E virus replication
Wißing M, Meister T, Nocke M, Gömer A, Masovic M, Knegendorf L, Brüggemann Y, Bader V, Siddharta A, Bock C, Ploss A, Kenney S, Winklhofer K, Behrendt P, Wedemeyer H, Steinmann E, Todt D
2024One Health (amsterdam, Netherlands)18 : 100674
Immunisation of pigs with recombinant HEV vaccines does not protect from infection with HEV genotype 3
Dähnert L, Aliabadi E, Fast C, Hrabal I, Schröder C, Behrendt P, Protzer U, Groschup M, Eiden M
2024Jhep Reports : Innovation in Hepatology6 (3) : 100989
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Gömer A, Dinkelborg K, Klöhn M, Jagst M, Wißing M, Frericks N, Nörenberg P, Behrendt P, Cornberg M, Wedemeyer H, Steinmann E, Maasoumy B, Todt D
2023Hepatology (baltimore, Md.)78 (6) : 1882-1895
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients
Gömer A, Klöhn M, Jagst M, Nocke M, Pischke S, Horvatits T, Schulze Zur Wiesch J, Müller T, Hardtke S, Cornberg M, Wedemeyer H, Behrendt P, Steinmann E, Todt D
